[1]褚春沐.奥拉西坦联合甘露醇改善脑出血后脑水肿的效果观察[J].医学信息,2022,35(19):127-129.[doi:10.3969/j.issn.1006-1959.2022.19.036]
　CHU Chun-mu.Effect Observation of Oxiracetam Combined with Mannitol in Improving Cerebral Edema After Cerebral Hemorrhage[J].Journal of Medical Information,2022,35(19):127-129.[doi:10.3969/j.issn.1006-1959.2022.19.036]
点击复制

奥拉西坦联合甘露醇改善脑出血后脑水肿的效果观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年19期
页码:
127-129
栏目:
药物与临床
出版日期:
2022-10-01

文章信息/Info

Title:
Effect Observation of Oxiracetam Combined with Mannitol in Improving Cerebral Edema After Cerebral Hemorrhage
文章编号:
1006-1959（2022）19-0127-03
作者:
褚春沐
（佳木斯市中心医院神经内科，黑龙江 佳木斯 154002）
Author(s):
CHU Chun-mu
(Department of Neurology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China)
关键词:
奥拉西坦; 甘露醇; 脑出血; 脑水肿
Keywords:
Oxiracetam; Mannitol; Cerebral hemorrhage; Cerebral edema
分类号:
R743.34
DOI:
10.3969/j.issn.1006-1959.2022.19.036
文献标志码:
A
摘要:
目的 观察奥拉西坦联合甘露醇治疗脑出血后脑水肿的临床效果。方法 选取2020年3月-2021年3月在我院诊治的56例脑出血后脑水肿患者为研究对象，采用随机数字表法分为对照组和观察组，各28例。对照组采用甘露醇治疗，观察组在对照组基础上联合奥拉西坦治疗；比较两组临床疗效、脑水肿和脑血肿体积、神经功能缺损（NIHSS）评分、颅内压、日常生活活动能力（Bathel）评分及不良反应发生情况。结果 观察组治疗总有效率为92.86%，高于对照组的82.14%（P＜0.05）；观察组脑水肿、脑血肿体积均小于对照组（P＜0.05）；两组NIHSS评分均低于治疗前，且观察组低于对照组（P＜0.05）；观察组颅内压低于对照组，Bathel评分高于对照组（P＜0.05）；两组不良反应发生率比较，差异无统计学意义（P＞0.05）。结论 奥拉西坦联合甘露醇治疗脑出血后脑水肿效果确切，可降低患者NIHSS、Bathel评分及颅内压，缩小脑水肿和脑血肿体积，且不良反应少，是一种安全有效的治疗方案。
Abstract:
Objective To observe the clinical effect of oxiracetam combined with mannitol in the treatment of cerebral edema after cerebral hemorrhage.Methods A total of 56 patients with cerebral edema after cerebral hemorrhage diagnosed and treated in our hospital from March 2020 to March 2021 were selected as the research objects. They were divided into control group and observation group by random number table method, with 28 cases in each group. The control group was treated with mannitol, and the observation group was treated with oxiracetam on the basis of the control group. The clinical efficacy, cerebral edema and hematoma volume, neurological deficit score (NIHSS), intracranial pressure, activity of daily living (Bathel) score and adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 92.86%, which was higher than 82.14% in the control group (P<0.05). The volume of cerebral edema and cerebral hematoma in the observation group was smaller than that in the control group (P<0.05). The NIHSS scores of the two groups were lower than those before treatment, and the observation group was lower than the control group (P<0.05). The intracranial pressure of the observation group was lower than that of the control group, and the Bathel score was higher than that of the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusion Oxiracetam combined with mannitol is effective in the treatment of cerebral edema after cerebral hemorrhage, which can reduce NIHSS, Bathel score and intracranial pressure, reduce cerebral edema and cerebral hematoma volume, and has fewer adverse reactions. It is a safe and effective treatment.

参考文献/References:

[1]曾宏.吡拉西坦联合甘露醇对脑出血后脑水肿患者神经肽Y水平及神经功能的影响[J].西藏医药,2017(4):41-42.[2]黄智勇,黄金根,周小华,等.吡拉西坦注射液联合甘露醇注射液治疗脑出血后脑水肿的疗效观察[J].中国医院用药评价与分析,2017,17(4):497-498,501.[3]吕超,秦龙,黄胜明.联合应用甘露醇、单唾液酸神经节苷脂对脑出血致脑水肿的临床疗效及对神经功能的影响[J].中国生化药物杂志,2017,37(1):172-175.[4]陈思.吡拉西坦联合甘露醇治疗脑出血患者脑水肿的效果观察[J].临床合理用药杂志,2018,11(7):14-15,17.[5]陈普.吡拉西坦注射液联合甘露醇对脑出血后脑水肿患者颅内压及神经功能的影响[J].内蒙古医学杂志,2020,52(5):530-532.[6]中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国脑出血诊治指南(2019)[J].中华神经科杂志,2019,52(12):994-1005.[7]Amagasa S,Matsui H,Tsuji S,et al.Characteristics distinguishing abusive head trauma from accidental head trauma in infants with traumatic intracranial hemorrhage in Japan[J].Acute Med Surg,2018,5(3):265-271.[8]贺新霞.影响青年与老年急性原发性脑出血患者血肿吸收速度相关因素分析[J].社区医学杂志,2017,15(20):47-49.[9]刘乃彦,张化民.脑血疏口服液联合神经节苷脂治疗急性脑出血的疗效观察[J].现代药物与临床,2016,31(12):1901-1904.[10]吴金平,陈小枫,王丹丹,等.序贯肠内营养治疗对出血性脑卒中合并吞咽功能障碍患者NIHSS评分、内毒素、二胺氧化酶水平及预后的影响[J].临床与病理杂志,2019,39(6):1220-1225.[11]苏伟煌.奥拉西坦联合甘油果糖治疗糖尿病并脑出血后脑水肿的价值分析[J].中国医药科学,2020,10(23):120-123. [12]陈玲玲,何文龙,周琳.甘露醇联合托拉塞米治疗脑出血后急性脑水肿对照研究[J].临床心身疾病杂志,2018,24(5):58-60,90.[13]李玉金.呋塞米与托拉塞米对急性脑出血患者脑水肿的影响研究[J].中国处方药,2018,16(9):80-81.[14]王欢,林忠,袁京宁,等.吡拉西坦联合甘露醇对老年脑出血后脑水肿的疗效比较[J].现代生物医学进展,2016,16(30):5900-5903.[15]戢艳丽,杨阳,黄克芬,等.无创监护性护理在甘露醇治疗急性脑出血后迟发性脑水肿患者中的应用[J].西部医学,2016,28(6):870-873.[16]徐希德,施炜,陈建,等.依达拉奉联合地塞米松静脉注射对急性脑出血患者术后脑水肿的预防效果[J]山东医药,2016,56(39):64-66．[17]Okubo Y,Ueta Y,Taguchi T,et al.A case of meningeal carcinomatosis mimicking subarachnoid hemorrhage on MRI[J].Rinsho Shinkeigaku (Clinical Neurology),2018,58(6):403-406.[18]黄绍精,曲军,陈新.托拉塞米与呋塞米治疗急性脑出血后脑水肿疗效[J].宁夏医科大学学报,2016,38(7):807-810.[19]朱金虎.甘露醇联合阿替普酶静脉溶栓对后循环脑梗死患者神经功能缺损评分的影响[J].中国药物与临床,2020,20(3):445-447.[20]马进海,汪涛.奥拉西坦联合银杏叶提取物治疗急性脑出血疗效分析及其对血清炎性因子的影响[J].中国现代神经疾病杂志,2019,19(8):588-596.

相似文献/References:

[1]李 丹.奥拉西坦和吡拉西坦治疗老年脑出血后认知功能障碍的疗效比较[J].医学信息,2019,32(24):117.[doi:10.3969/j.issn.1006-1959.2019.24.041]
　LI Dan.Efficacy Comparison of the Oxiracetam and Piracetam in the Treatment of Cognitive Impairment in Elderly Patients with Cerebral Hemorrhage[J].Journal of Medical Information,2019,32(19):117.[doi:10.3969/j.issn.1006-1959.2019.24.041]
[2]彭 亮.甘露醇治疗早期脑出血对血肿扩大及预后的影响[J].医学信息,2020,33(17):155.[doi:10.3969/j.issn.1006-1959.2020.17.046]
　PENG Liang.The Effect of Mannitol Treatment of Early Cerebral Hemorrhage on Hematoma Enlargement and Prognosis[J].Journal of Medical Information,2020,33(19):155.[doi:10.3969/j.issn.1006-1959.2020.17.046]
[3]彭 亮.地塞米松联合甘露醇治疗对急性重症脑血管病脑保护作用的临床观察[J].医学信息,2020,33(18):145.[doi:10.3969/j.issn.1006-1959.2020.18.048]
　PENG Liang.Clinical Observation of the Protective Effect of Dexamethasone Combined with Mannitol on the Cerebral Protection of Acute Severe Cerebrovascular Disease[J].Journal of Medical Information,2020,33(19):145.[doi:10.3969/j.issn.1006-1959.2020.18.048]
[4]黄晓聪,王秋香,邱锦华.不同剂量甘露醇治疗高血压性脑出血患者降颅压效果的临床研究[J].医学信息,2021,34(22):124.[doi:10.3969/j.issn.1006-1959.2021.22.038]
　HUANG Xiao-cong,WANG Qiu-xiang,QIU Jin-hua.Clinical Study on the Effect of Different Doses of Mannitol in the Treatment of Hypertensive Cerebral Hemorrhage[J].Journal of Medical Information,2021,34(19):124.[doi:10.3969/j.issn.1006-1959.2021.22.038]

更新日期/Last Update: 1900-01-01